Form 4: UAMY Director Sells Shares Under 10b5-1 Plan

United States Antimony Corp Director Blaise A. Aguirre sold 27,000 shares of common stock on March 31, 2026, under a pre-arranged 10b5-1 trading plan.

Summary

• Blaise A. Aguirre, a Director of United States Antimony Corp (UAMY), reported the disposition of common stock.
• The transactions occurred on March 31, 2026.
• A total of 27,000 shares were sold across five separate transactions.
• The shares were sold at prices ranging from $8.20 to $8.26 per share.
• Following these transactions, Blaise A. Aguirre beneficially owns 845,754 shares of common stock.
• The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event because the sale was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled transaction rather than a reaction to new material information.

Negatives

• Director Blaise A. Aguirre disposed of a total of 27,000 shares of United States Antimony Corp common stock.

Industry Context

StockSavvy.ai notes that insider sales, especially by directors, are closely watched by the market for potential signals about a company's future prospects. However, sales executed under a Rule 10b5-1 plan are pre-scheduled and typically do not signal a change in the insider's view of the company's prospects, as the plan is established when the insider is not in possession of material non-public information. This type of transaction is often for personal financial planning purposes.

Stakeholder Impact

• Shareholders may note the reduction in a director's direct holdings, but the pre-arranged nature of the 10b5-1 plan mitigates concerns about negative signaling regarding the company's future performance.

Key Dates

Recommendation

The sale by a director, while a reduction in their direct holdings, was executed under a pre-arranged 10b5-1 plan. This suggests the transaction was scheduled in advance and not based on new, material non-public information, thus it does not inherently signal a change in the company's fundamental prospects. Investors should maintain their current position and look for broader company performance indicators.

Keywords

UAMY, United States Antimony Corp, Form 4, insider trading, stock sale, director, Blaise Aguirre, 10b5-1 plan